Jean W. Marstiller
Secretario Corporativo en CUMBERLAND PHARMACEUTICALS INC. .
Perfil
Jean W.
Marstiller is currently working as the Secretary & Senior VP-Administrative Services and Secretary & Senior Vice President at Cumberland Pharmaceuticals, Inc. since 2012.
Previously, Jean worked as the Director-Administrative Operations at Therapeutic Antibodies, Inc. from 1989 to 1998 and as a Principal at Brown-Forman Corp.
from 1982 to 1987.
Jean completed their undergraduate degree at Vanderbilt University.
Cargos activos de Jean W. Marstiller
Empresas | Cargo | Inicio |
---|---|---|
CUMBERLAND PHARMACEUTICALS INC. | Secretario Corporativo | 06/01/1999 |
Antiguos cargos conocidos de Jean W. Marstiller.
Empresas | Cargo | Fin |
---|---|---|
Therapeutic Antibodies, Inc.
Therapeutic Antibodies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., Therapeutic Antibodies, Inc. is a biopharmaceutical company that specializes in research and development to produce polyclonal antibodies. The company is based in Nashville, TN. Therapeutic Antibodies was acquired by Protherics Plc on September 15, 1999 for $38.46 million. | Director Administrativo | 01/01/1998 |
BROWN-FORMAN CORPORATION | Corporate Officer/Principal | 01/01/1987 |
Formación de Jean W. Marstiller.
Vanderbilt University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
CUMBERLAND PHARMACEUTICALS INC. | Health Technology |
BROWN-FORMAN CORPORATION | Consumer Non-Durables |
Empresas privadas | 1 |
---|---|
Therapeutic Antibodies, Inc.
Therapeutic Antibodies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., Therapeutic Antibodies, Inc. is a biopharmaceutical company that specializes in research and development to produce polyclonal antibodies. The company is based in Nashville, TN. Therapeutic Antibodies was acquired by Protherics Plc on September 15, 1999 for $38.46 million. | Commercial Services |
- Bolsa de valores
- Insiders
- Jean W. Marstiller